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ABSTRACT 23 
The effects of cryopreservation on mesenchymal stem cell (MSC) phenotype are not well documented; however 24 
this process is of increasing importance for regenerative therapies.  This study examined the effect of 25 
cryopreservation (10% dimethyl-sulfoxide) on the morphology, viability, gene-expression and relative 26 
proportion of MSC surface-markers on cells derived from rat adipose, bone marrow and dental pulp.  27 
Cryopreservation significantly reduced the number of viable cells in bone marrow and dental pulp cell 28 
populations but had no observable effect on adipose cells.  Flow cytometry analysis demonstrated significant 29 
increases in the relative expression of MSC surface-markers, CD90 and CD29/CD90 following 30 
cryopreservation.  sqRT-PCR analysis of MSC gene-expression demonstrated increases in pluripotent markers 31 
for adipose and dental pulp, together with significant tissue-specific increases in CD44, CD73 and CD105 32 
following cryopreservation.  Cells isolated from different tissue sources did not respond equally to 33 
cryopreservation with adipose tissue representing a more robust source of MSCs. 34 
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INTRODUCTION 47 
Non-hematopoietic stem cells have been described in many tissues and were originally termed fibroblastic 48 
colony-forming-units because they readily adhered to culture dishes and formed colonies of fibroblast-like cells 49 
[2, 20-23]. These cells are currently referred to as mesenchymal stem cells (MSCs) [1] because of their ability to 50 
differentiate into a variety of mesenchymal cell types such as adipose tissue, cartilage and bone [20-23].  MSCs 51 
were first identified in the bone marrow but have since been isolated from almost every tissue in the body [1, 8, 52 
28].  Dental stem cells isolated from the gelatinous pulp region of the tooth were identified by Gronthos et al 53 
(2000), and have been employed for a wide range of regenerative therapies, most prominently neuronal and 54 
orthopaedic therapies [8, 13, 26].  Of the large number of tissues from which MSCs have been isolated adipose 55 
tissue is perhaps the most clinically useful, since this tissue contains relatively large numbers of stem cells 56 
(≤10%) when compared with the bone marrow (0.001-0.1%) that can be isolated in large volumes, relatively 57 
non-invasively with minimal patient discomfort [25, 28]. 58 
 59 
The capacity of mesenchymal stem cells (MSCs) to survive long-term storage and maintain their phenotype 60 
upon thawing is critical if they are to be banked and used for future therapeutic purposes.  Reductions in cell 61 
viability and alterations in the expression of gene and phenotypic cell surface markers may have implications for 62 
the therapeutic application of MSC, including reduced functional and differentiation capacity.  Cryostorage 63 
represents a physical insult to cells resulting in structural and molecular changes within cells.  To protect cells 64 
from damage during the cryopreservation process and to maximise cell recovery cryoprotectants are 65 
incorporated within the freezing medium.  The concentration of cryoprotectants added to the medium is one of 66 
the primary factors governing the survival of frozen cells.  The majority of published cryopreservation protocols 67 
incorporate 10% DMSO in order to prevent the formation of intra- and extra-cellular crystals during the freezing 68 
process [4, 24].  However, recent studies have reported that the survival and number of colonies formed by 69 
MSCs is significantly decreased following cryostorage and that the magnitude of this decrease is inversely 70 
proportional to DMSO concentration [19].  Moreover, the use of DMSO as a cryoprotectant has been shown to 71 
be ineffective at protecting some cell types from cold shock (0 - +8°C) during the freezing process [11], 72 
highlighting the need for further investigation into the effects of cryostorage using 10% DMSO on MSC 73 
viability and self-renewal.   74 
  
It is presently unknown whether post-thaw MSCs retain the same potential for regenerative therapeutic 75 
applications as their non-cryopreserved counterparts.  The response of stem cells to cryopreservation can include 76 
a reduction in cell viability due to cold-shock and/or the toxic effects of DMSO, and changes in the expression 77 
of stem cell-related markers, cytoskeletal disassembly, delayed apoptosis, and osmotic and oxidative stresses 78 
[27].  These factors may have an influence on the functionality of MSCs and reduce their applicability for 79 
regenerative therapies.  It has subsequently been suggested that the effects of cryopreservation may be 80 
responsible for the failure of a randomised phase III clinical trial using random donor MSCs in the treatment of 81 
steroid resistant graft-versus-host disease (NCT00366145) [7].  At present, much of the information concerning 82 
the effects of cryopreservation on MSCs is difficult to interpret as studies frequently isolate MSCs from 83 
different tissue sources and store them for variable periods of time [17, 22]. 84 
In the present study, we examined the effect of 14 days cryostorage on the viability, morphology, gene 85 
expression and immunophenotype of adipose-derived cells (ADCs), bone marrow cells (BMCs) and dental pulp 86 
cells (DPCs) derived from rats.  The rat was used as a model since MSCs isolated from this species have a very 87 
similar cell-surface marker profile and differentiation potential when compared with human MSCs [9].  The use 88 
of a rat model also enabled the comparison of cells isolated from several tissues within the same animal, thereby 89 
limiting potential error caused by intra-species variation.  A traditional graded freezing protocol (4°C, 1 hour; -90 
20°C, 2 hours; -80°C, overnight; -136°C, 14 days) was adopted throughout this study since previous work has 91 
demonstrated that this method is no less effective in maintaining post-thaw viability of MSCs compared with 92 
controlled freezing, with consistent nucleation observed [18].  This work was undertaken to determine if 93 
cryopreservation with 10% DMSO affected the viability and the capacity of ADCs, BMCs and DPCs to survive 94 
fluorescence-activated cell sorting (FAC), which is arguably the most routinely used procedure for MSC 95 
isolation.  The effect of cryopreservation on the cell-surface marker profile of MSCs was analysed using FACS 96 
to assess whether cryopreservation influenced the proportion of MSCs within heterogeneous cultures.  97 
Additionally, the expression profiles of pluripotent/multipotent genes between cryopreserved and non-98 
cryopreserved cells were compared, as changes in these transcripts may alter their functionality and 99 
differentiation potential, and may therefore limit the clinical potential of these cells.  100 
METHODS 101 
Cell culture 102 
  
Adipose, bone marrow and dental pulp tissues were isolated from six week old male Wister Hann rats (weight 103 
~120g) (Aston University, Pharmaceutical Sciences Animal House, Birmingham, UK; ethical approval 104 
reference: BCHDent286.1471.TB).  Cells were isolated from each tissue using a standard protocol [6]. 105 
Cryopreservation of cell isolates 106 
To prepare cells for cryostorage, ~80% confluent passage 1 cultures containing approximately 2.5 x 10
6
 cells per 107 
75cm
2
 culture flask (Nunc, UK) were detached using 0.25% trypsin, 1mM EDTA
.
4Na (2.5g/L trypsin in 108 
0.38g/L EDTA) (Gibco, UK), and centrifuged at 900g for a period of 5 minutes.  The supernatant was aspirated 109 
and an equal volume of cells re-suspended in 0.4% Trypan blue solution to provide a cell viability count.  1 x 110 
10
6
 cells were re-suspended in cryogenic medium [90% FBS containing 10 % dimethyl sulfoxide (DMSO)] [15] 111 
and the cell suspensions transferred to cryogenic vials that were prepared for liquid nitrogen storage by 112 
incubation at 4ºC for 1 hour, then at -20ºC for 2 hours and subsequently -80ºC overnight.  Frozen cell 113 
suspensions were then transferred to liquid nitrogen storage.   10 vials of cryostored cells were recovered from 114 
storage by thawing in a 37ºC RS Galaxy S+ incubator (RS Biotech, UK) for ~5 minutes.  To remove residual 115 
cryogenic medium prior to culture, the contents of each vial were transferred to 15mL Falcon
®
 tubes containing 116 
5mL α-MEM + 10% FBS and centrifuged at 900g for 5 minutes.  Cell viability was measured immediately after 117 
thawing using the Trypan blue exclusion assay and approximately 2 x 10
5
 cells seeded in 25cm
2
 culture flasks 118 
(Nunc, UK).  Cells were cultured to approximately 80% confluence, at which point Trypan blue cell counts 119 
were performed and population doubling times (PDT) calculated using the following equation:  120 
PDT = T ln2/ln(Xe/Xb) 121 
T = incubation time, Xb = cell number at the beginning of incubation, Xe = cell number at the end of incubation 122 
Cell viability during flow cytometry 123 
To examine the capacity of cryostored cells to undergo flow cytometric cell sorting, cryostored and non-124 
cryostored cells established at passage 2 were cultured until ~80% confluent (80% confluency was reached after 125 
5 days for ADCs and BMCs, and after 7 days for DPCs).  Cells were detached using 0.25% trypsin, 1mM 126 
EDTA
.
4Na (2.5g/L trypsin in 0.38g/L EDTA) (Gibco, UK), centrifuged at 900g for 5 minutes, neutralised with 127 
α-MEM + 10% FBS and the resulting suspensions transferred to 15mL Falcon® tubes.  Cell suspensions were 128 
incubated in FACS buffer (sterile PBS + 1% FBS) and maintained under constant agitation using an orbital 129 
shaker, mimicking conditions experienced during flow cytometry.  The number of viable cells was determined 130 
  
every 30 minutes during this incubation period at 4ºC for a total period of 5 hours by adding 0.4% Trypan blue 131 
solution to an equal volume of cell suspension and manually counting the cells using an improved Neubauer 132 
haemocytometer.   133 
Cell characterisation 134 
Cryostored and non-cryostored passage 2 ADCs, BMCs and DPCs were expanded in vitro, and after reaching 135 
~80% confluence were analysed using fluorescence activated cell sorting (FACS).  All analyses were performed 136 
on the same day.  The presence of MSC surface antigens was determined using a FACSAriaII flow cytometer 137 
(BD Pharmingen, UK).  MSC surface antigens CD29-APC (eBiosciences, 17-0291) and CD90-FITC 138 
(eBiosciences, 11-0900) were analysed using flow cytometry as previously described [5].  Semi-quantitative 139 
reverse transcription PCR (sqRT-PCR) was used to assess the expression of CD44, CD73 and CD105 in 140 
cryopreserved and non-cryopreserved cell cultures.  For sqRT-PCR analysis ~80% confluent ADC, BMC and 141 
DPC cultures were isolated at passage 2 and compared with cryopreserved cells that had been cultured to ~80% 142 
confluency at the same passage.  RNA was isolated using an RNeasy minikit (Qiagen, UK).  RNA was reverse 143 
transcribed using an Omniscript RT kit (Qiagen, UK) according to the manufacturer’s instructions.  The 144 
housekeeping gene GAPDH was used for normalisation.  Primers details are listed in Appendix table 1. 145 
Statistical analysis 146 
All data was analysed using the statistical package SPSS 10.0 for Windows (SPSS Inc., USA).  Statistical 147 
analyses were performed using one way analysis of variance (ANOVA), followed by the Bonferroni post hoc, 148 
P<0.05 was considered to indicate statistical significance. For all experiments n indicates the number of 149 
experiments performed, with each experiment containing a total of three replicates. 150 
RESULTS AND DISCUSSION 151 
Following cryopreservation recovered ADCs, BMCs and DPCs exhibited a fibroblast-like morphology (Fig. 1a).  152 
However, it cannot be ruled out that ultrastructural changes occurred, as was recently shown by James et al 153 
(2011) who described changes in ADC morphology following cryopreservation [10].  ADCs, BMCs and DPCs 154 
harvested at passage 1 all exhibited >95% viability before being place in cryostorage, which correlated with a 155 
previous study [3] (Fig. 1b).  Following cryostorage the proportion of viable cells was not statistically (P<0.05) 156 
lower than when harvested, >90% for each cell type (Fig. 1b).  The effects of in vitro expansion following 157 
cryopreservation on cell viability was found to be cell-type specific, with average numbers of viable cells in 158 
  
ADC, BMC and DPC populations of 94%, 57% and 89% respectively immediately following post-thaw culture 159 
(Fig. 1c, 1d and 1e).  The fact that significant (P<0.05) reductions in cell viability only became apparent 160 
following expansion and not immediately after thawing corroborates the findings of Naaldijk et al (2012), but 161 
demonstrates that the results were only significant (P<0.05) for BMCs [18].  Reductions in BMC viability 162 
following cryostorage may be related to the fact that bone marrow contains a relatively low proportion of stem 163 
cells (0.001-0.1%) when compared with adipose tissue (≤10%) and dental pulp (≤1%) [8, 24, 27].  Therefore, it 164 
is possible that the reduction in the viability of cells in the BMC population corresponded to nucleated non-165 
progenitor cells, since these cells have been shown to have a comparatively high sensitivity to cryostorage when 166 
compared with MSCs [14].  Such non-progenitor cells may comprise MSCs that have undergone differentiation 167 
or other heterogeneous tissue components that not been successfully eliminated during cell culture.  Suspension 168 
of the cells in FACS buffer, as would be required if the cells were to be used for cell sorting during flow 169 
cytometry resulted in a further and significant (P<0.05) reduction in cell viability for both BMCs and DPCs 170 
(Fig. 1d and e), but had no significant effect on ADCs (Fig. 1c).  The reduction in BMC and DPC viability when 171 
maintained in a low nutrient FACS buffer may be a lasting result of cell damage occurring due to hyperosmotic 172 
stress, differences in the concentrations of intracellular salts, membrane alterations or the toxic effects of DMSO 173 
during the freezing process [16].  It is unlikely that these findings are a result of time spent in culture since both 174 
BMCs and ADCs took approximately the same time to reach ~80% confluence (5 days) with similar population 175 
doubling times observed (ADCs, 51.68hrs; BMCs, 53.85hrs), while DPCs took comparatively longer to reach 176 
confluence (7 days, with a PDT of 72.35hrs) but maintained a higher proportion of viable cells than BMCs 177 
following post-thaw expansion, and significantly (P<0.05) higher viability than BMCs when maintained in 178 
FACS buffer.  The data collected in this study may support the hypothesis that adipose tissue contains a more 179 
robust source of MSCs that are able to survive out of culture for longer periods than MSCs isolated from bone 180 
marrow or dental pulp tissues [12].  These findings are interesting given that adipose tissue has recently been 181 
shown to contain a population of multi-lineage differentiating stress-enduring (Muse) cells that are able to 182 
endure extreme stresses such as hypoxia, serum deprivation, long term exposure to proteolytic enzymes such as 183 
collagenase, and low temperatures [12].  Similar cells with the ability to survive extreme stress within bone 184 
marrow and dental pulp tissues have not yet been described.  The presence of a more robust source of MSCs in 185 
adipose tissue may have significant implications when selecting an appropriate stem cell source for regenerative 186 
therapies.   187 
  
It is important to examine the effect of cryopreservation on MSC gene expression to provide an insight into 188 
molecular changes that occur following cell freezing, and may shed light on the self-renewal and differentiation 189 
capacity of cells following banking.  This study presents novel data demonstrating the influence of cryostorage 190 
on the expression of MSC-associated markers in ADC, BMC and DPC populations, evaluated using sqRT-PCR 191 
gene expression analysis and FACS profiling.  These analyses showed relatively high levels of expression of 192 
MSC-associated markers CD73, CD90 and CD105 for ADC cultures, CD44 and CD105 for BMC cultures, and 193 
CD73 and CD44 for DPC cultures following cryopreservation (Fig. 2 and 3).  Genes associated with stem cell 194 
maintenance and pluripotency such as Klf4, Lin28 and Nanog were also increased following cryopreservation of 195 
ADC and DPC cultures (Fig. 3).  Interestingly, in this study a reduction in cell viability following 196 
cryopreservation of DPCs and ADCs coincided with a proportional increase in the number of MSC markers, 197 
potentially implying positive MSC selection during cryostorage.  The finding that the expression of pluripotent 198 
markers in BMC cultures was not altered following cryopreservation and subsequent culture, coupled with the 199 
appreciable reduction in the overall viability of BMC cultures may indicate that the population of stem cells 200 
present within bone marrow isolates decreased following cryopreservation, and that this reduced viability was 201 
not solely due to the loss of non-progenitor cells [14].  These results suggest that MSCs present within the bone 202 
marrow may be more susceptible to hyperosmotic damage resulting from cryopreservation.  Additionally, ADCs 203 
and DPCs showed increases in the expression of transcription factors first identified with the maintenance of 204 
multi-potency and self- renewal in embryonic stem cells, such as Nanog, Lin28 and Klf4.  These results indicate 205 
that cryopreservation may alter the expression profile of genes associated with maintaining multipotency, 206 
thereby having an effect on the relative "stemness" of heterogeneous adipose and dental pulp cultures.  207 
This study has shown that cryopreservation in a routinely used cryopreservation medium (10% DMSO) led to 208 
reduced cell viability and an altered FACS profile, which has implications when comparing freshly isolated and 209 
cryopreserved cells using flow cytometry, and may influence the clinical translatability of cryopreserved cells.  210 
Post-thaw viabilities of cells isolated from different tissue sources differed significantly, with adipose tissue 211 
containing a more robust stem cell source than dental pulp and bone marrow.  Additionally, cryopreservation 212 
increased the proportion of MSC surface markers in ADC, BMC and DPC cultures, and genes associated with 213 
self-renewal and multipotency in ADC and DPC cultures, which is potentially indicative of a decline in 214 
heterogeneity and subsequent increase in the relative proportion of MSCs after thawing.  These data indicate 215 
that cells isolated from different anatomical locations do not respond equally to cryopreservation and that 216 
  
adipose tissue may be a more viable source MSCs for cell banking.  Further studies will need to be conducted 217 
using human cells to corroborate these findings. 218 
 219 
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FIGURE LEGENDS 298 
Figure 1. (a) Representative phase contrast photomicrographs comparing passage 2 ADSCs, BMSCs and 299 
DPSCs that had been cryopreserved (cryo) in FBS + 10% DMSO for 14 days with cells of the same passage that 300 
had not experienced cryopreservation.  (b) Viability was measured before cells were placed into cryostorage and 301 
immediately after thawing.  Following cryostorage cells were thawed and cultured until ~80% confluent.  302 
Following the in vitro expansion of cryostored and non-cryostored cells at passage 2, percentage viability was 303 
measured for (c) ADSCs, (d) BMSCs and (e) DPSCs while maintained in FACS buffer over a period of 270 304 
minutes to mimic conditions experience during cell selection (mean ±SD, n=10).  *P<0.05.  Trypan blue cell 305 
counts performed every 30 minutes to determine proportional cell viability. 306 
Figure 2. (a) Representative flow cytometry profiles for cryopreserved and non-cryopreserved ADSC, BMSC 307 
and DPSC populations established at passage 2.  Y-axis represents the percentage of positive cells within a 308 
manually defined area that was selected to exclude dead/clumped cells.  (b) Analysis of the proportion of CD29, 309 
CD90 and CD29/CD90 cell surface antigens presented by cryopreserved (cryo) and non-cryopreserved cells 310 
derived from (i) adipose, (ii) bone marrow and (iii) dental pulp established at passage 2 (mean ±SD, n=10).  311 
*P<0.05 312 
Figure 3. Comparative sqRT-PCR analysis of (a) pluripotency and (b) multipotency markers on cryopreserved 313 
and non-cryopreserved cells derived from adipose (AD), bone marrow (BM) and dental pulp (DP) established at 314 
passage 2.  All cells were cultured until ~80% confluent prior to RNA isolation (mean ±SD, n=10).  *P<0.05 315 
 316 
APPENDIX 317 
Table. 1 DNA sequences, annealing temperatures, and cycle numbers for primers used in the sqRT-PCR 318 
reaction.  All primers were designed using Primer Blast software (http://ncbi.nlm.nih.gov/tools/primer-blast/) 319 
and manufactured by Invitrogen, UK. 320 
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Gene Name 
Sequence 
(5’      3’) 
Annealing 
Temperature (°C) 
Cycle 
Number 
Accession 
Number 
Normalisation 
GAPDH 
F-CCCATCACCATCTTCCAGGAGC; 
R-CCAGTGAGCTTCCCGTTCAGC 
60.5 21-27 NM_017008 
Pluripotent Markers 
Klf4 
F-ATCATGGTCAAGTTCCCAGC; 
R-ACCAAGGACCATCGTTTAGG 
60.5 35 NM_052713 
C-myc 
F-CTTACTGAGGAAACGGCGAG; 
R-GCCCTATGTACACCGGAAGA 
60.5 35 BC091699 
Nanog 
F-TATCGTTTTGAGGGGTGAGG; 
R-CAGCTGGCACTGGTTTATCA 
60.5 35 NM_001100781 
Lin28 
F-TTTCTTGTTTCCCCCAAATG; 
R-AGAGGGGCTGGTTGTAAGGT 
60.5 35 NM_001109269 
SOX-2 
F-ATACAAGGGAATTGGGAGGG; 
         R-AAACCCAGCAAGAACCCTTT 
60.5 25 NM_001109181 
Multipotent Markers 
CD44 
F-TGGGTTTACCCAGCTGAATC; 
R-CTTGCGAAAGCATCAACAAA 
60.5 33-37 NM_012924.02 
CD105 
F-TTCAGCTTTCTCCTCCGTGT; 
R-TGTGGTTGGTACTGCTGCTC 
60.5 41-45 NM_001010968 
CD73  
F-GGACTGATTGATCCCCTCCT; 
R-TTGTCCCTGGATTTGAGAGG 
60.5 25 NM_002526 
CD29 
F-AATGGAGTGAATGGGACAGG; 
R-TCTGTGAAGCCCAGAGGTTT 
60.5 25 NM_017022.2 
CD90 
F-AGCTCTTTGATCTGCCGTGT; 
R-CTGCAGGCAATCCAATTTTT 
60.5 26 NM_012673 
 
